# Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis

> **NCT06543550** · PHASE4 · RECRUITING · sponsor: **Bio Meds Pharmaceutica Ltda** · enrollment: 70 (estimated)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Implantable gestrinone
- **DRUG:** Oral Dienogest

## Key facts

- **NCT ID:** NCT06543550
- **Lead sponsor:** Bio Meds Pharmaceutica Ltda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-30
- **Primary completion:** 2025-09
- **Final completion:** 2025-10
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06543550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06543550, "Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06543550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*